Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4
Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4 Why Abiomed (ABMD) Shares Are Soaring Today – Abiomed (NASDAQ:ABMD) – Stocks to Watch
Johnson & JohnsonJNJ has agreed to acquireAbiomed IncABMD for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion.
Abiomed shareholders will also receive a non-tradeable contingent value right (CVR), entitling the holder to receive up to $35.00 per share in cash if certain commercial and clinical milestones are achieved.
The transaction broadens Johnson & Johnson MedTech’s (JJMT) position in cardiovascular offerings.
Abiomed offers Impella heart pumps for patients with severe coronary artery disease requiring high-risk PCI (percutaneous coronary intervention), treatment of AMI (acute myocardial infarction), cardiogenic shock, or right heart failure.
Johnson & Johnson expects the transaction to be slightly dilutive to neutral to adjusted EPS in the first year, and then accretive by approximately $0.05 in 2024, and increasingly accretive after that.
The transaction is expected to be completed by Q1 of 2023.
